semaglutide fda approval weight loss Is GLP-1 Safe for Loss? FDA approves higher dose of

In 68 weeks (about a year and a half), people taking Wegovy lost nearly 15% of their body weight (~34 pounds)

46 Adverse Effects and Tolerability of GLP-1RAs in Clinical Practice Although the cardiovascular benefits of GLP-1RAs are significant, their use is commonly associated with well-characterised adverse effects that can affect tolerability and long-term medication adherence, as detailed below

The weight loss effects can enable patients to do activities they couldn't do previously, like chase after grandchildren or find clothes that fit at mainstream stores

Slow Digestion and Increased Fullness One of the unique effects of semaglutide injections is their ability to slow down the stomachs emptying process, prolonging the feeling of fullness after meals

Results from clinical trials of FDA-approved products cannot be transferred directly to an individual using a compounded product in a telehealth program